Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: A randomized, multicenter, placebo-controlled clinical trial

American Journal of Gastroenterology

Volumn 93, Issue 1, 1998, Pages 61-65

  Dumot, John A ^a   Conwell, Darwin L ^a   Barry O'Connor, J ^a   Roy Ferguson, D ^a   Vargo, John J ^a   Barnes, David S ^a   Shay, Steven S ^a   Sterling, Mark J ^a   Horth, Kenneth S ^a   Issa, Khaled ^a   Ponsky, Jeffrey L ^a   Zuccaro, Gregory ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

A METHAPRED; METHYLPREDNISOLONE SODIUM SUCCINATE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREATITIS; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPHINCTEROTOMY;

ANALGESIA; ANTI-INFLAMMATORY AGENTS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LENGTH OF STAY; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PANCREATITIS; PARENTERAL NUTRITION; PLACEBOS; SPHINCTER OF ODDI;

EID: 0032426654     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.061_c.x     Document Type: Article

References (32)

1. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas. 6:1991;350-367.
2. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. NEJM. 335:1996;909-918.
3. Kimmey MB, Al-Kawas FH, Carr-Locke DL, et al. ASGE technology assessment status evaluation. Radiographic contrast media used in ERCP. Gastrointest Endosc. 43:1996;647-651.
4. Binmoeller KF, Harris AG, Dumas R, et al. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut. 33:1992;1129-1133.
5. JM Sternlieb, Aronchick CA, Retig JN, et al. A multicenter randomized controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol. 87:1992;1561-1566.
6. Persson B, Slezak P, Efendic S., et al. Can somatostatin prevent injection pancreatitis after ERCP? Hepato-Gastroenterol. 39:1992;259-261.
7. Arcidiacono R, Gambitta P, Rossi A, et al. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy. 26:1994;715-718.
8. Börsch G, Bergbauer M, Nebel W, et al. Der Einfluss von Somatostatin auf die Amylasespiegel und Pancreatitistrate nach ERCP. Med Welt. 35:1984;109-112.
9. Bordas JM, Toledo V, Mondelo F, et al. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy. Hormone Res. 29:1988;106-108.
10. Saari A, Kivilaakso E, Shroder T. The influence of somatostatin on pancreatic irritation after pancreatography: An experimental and clinical study. Surg Res Commun. 24:1988;271-274.
11. Testoni P, Masci E, Babnolo F, et al. Endoscopic papillosphincterotomy: Prevention of pancreatic reaction by somatostatin. Ital J Gastroenterol. 20:1988;70-73.
12. Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion. 54:1993;105-111.
13. Silvis SE, Vennes GA. The role of glucagon in endoscopic cholangio-pancreatography. Gastrointest Endosc. 21:1975;162-163.
14. Odes HS, Novis BN, Barbezat GO, et al. Effects of calcitonin on the serum amylase levels after endoscopic retrograde cholangiopancreatography. Digestion. 16:1977;180-184.
15. Koch H, Belohlavek D, Schaffner O, et al. Prospective study for the prevention of pancreatitis following endoscopic retrograde cholangio-pancreatography (ERCP). Endoscopy. 7:1975;221-224.
16. Burst R, Thompson ABR, Wensel RH, et al. Pancreatic injury following ERCP: Failure of prophylactic benefit of Trasylol™ Gastrointest Endosc. 24:1977;77-79.
17. Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. NEJM. 335:1996;919-923.
18. Weiner G, Geenen WJ, Hogan W, et al. Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc. 42:1995;579-583.
19. Pelot D, Berk JE, Fridhandler L. Serum isoamylase changes following endoscopy. Gastrointest Endosc. 24:1978;166-168.
20. Cotton PB, Lehman GA, Vennes, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc. 37:1991;383-393.
21. Siegel JH, Veerappan A, Tucker R. Bipolar versus monopolar sphincterotomy: A prospective trial. Am J Gastroenterol. 89:1994;1827-1830.
22. Gross V, Lesser HG, Scholmerich J. Inflammatory mediators and cytokines - New aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepato-Gastroenterol. 40:1993;522-530.
23. Messmann H, Vogt W, Holstege A, et al. Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut. 40:1997;80-85.
24. Kingsnorth A. Role of cytokines and their inhibitors in acute pancreatitis. Gut. 40:1997;1-4.
25. Lasser EC, Berry CC, Talner LB, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. New Engl J Med. 317:1987;845-849.
26. Morris HG. Mechanisms of action and therapeutic role of corticosteroids in asthma. J Allergy Clin Immunol. 75:1985;1-13.
27. Sherman S, Lehman G, Earle D, et al. Does prophylactic oral steroid administration reduce the frequency and severity of post-ERCP pancreatitis?: Randomized prospective multicenter study. Gastrointest Endosc. 45:1997;165. (abstract).
28. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surg. 117:1995;648-655.
29. Norman JG, Franz MG, et al. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg. 221:1995;625-634.
30. Van Laethem J, Marchant A, Delvaux A, et al. Interleukin-10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterol. 108:1995;1917-1922.
31. Rongione AJ, Kusske AM, Kwan K, et al. Interleukin 10 reduced the severity of acute pancreatitis in rats. Gastroenterol. 112:1997;960-967.
32. 1 esterase. Biochim Biophys Acta. 484:1977;417-422.